Workflow
HANRUI COBALT(300618)
icon
Search documents
寒锐钴业(300618) - 北京国枫律师事务所关于南京寒锐钴业股份有限公司调整2024年限制性股票激励计划授予价格的法律意见书
2025-06-18 08:52
北京国枫律师事务所 关于南京寒锐钴业股份有限公司 调整 2024 年限制性股票激励计划授予价格的 法律意见书 国枫律证字[2024]AN110-3 号 北京国枫律师事务所 Grandway Law Offices 北京市东城区建国门内大街 26 号新闻大厦 7 层 邮编:100005 电话(Tel):010-88004488/66090088 传真(Fax):010-66090016 北京国枫律师事务所 关于南京寒锐钴业股份有限公司 调整 2024 年限制性股票激励计划授予价格的 北京国枫律师事务所(以下简称"本所")接受南京寒锐钴业股份有限公司 (以下简称"寒锐钴业"或"公司")委托,根据《中华人民共和国公司法》(以 下简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、 《上市公司股权激励管理办法》(以下简称"《管理办法》")、《创业板上市 公司持续监管办法(试行)》(以下简称"《监管办法》")、《深圳证券交易 所创业板股票上市规则》(以下简称"《创业板上市规则》")、《深圳证券交 易所创业板上市公司自律监管指南第1号——业务办理》(以下简称"《监管指 南第1号》")等有关法律、法规 ...
钴出口禁令再延2个月!
鑫椤锂电· 2025-06-16 01:45
Core Viewpoint - The extension of the cobalt export ban in the Democratic Republic of Congo (DRC) is expected to significantly impact the cobalt market, leading to supply shortages and potential price increases, with companies like Huayou Cobalt and Hanrui Cobalt seeing substantial stock price gains as a result [1][2]. Supply and Demand Overview - DRC's cobalt production in 2024 is projected at 220,000 tons, accounting for 75.9% of global supply, with a monthly export of 18,000 tons. If the export ban is extended to six months, it could reduce exports by 108,000 tons, which is equivalent to 84% of China's cobalt demand for 2024 [1]. - China's cobalt supply is expected to decrease by 38% to 104,000 tons, while demand will slightly increase by 2.3% to 131,000 tons, resulting in a shift from a surplus of 42,000 tons to a shortage of 27,000 tons [1]. Industry Chain Impact - **Upstream Mining**: Non-DRC production is becoming a scarce asset. Huayou Cobalt's Indonesian capacity of 30,000 tons is expected to generate 5 billion yuan in revenue by 2025, despite being 10% more expensive than DRC production [2]. - **Midstream Smelting**: Companies like Greeenmei and Zhongwei Co. are adapting their raw material sources to reduce costs and mitigate risks associated with DRC's export policies [3]. - **Downstream Demand**: The electric vehicle sector is increasing cobalt procurement by 50% year-on-year, while the 3C battery sector is expected to see an 8% increase in cobalt demand, indicating differing responses to market conditions [4]. Investment Landscape - Focus on non-DRC production and recycling sectors is recommended. Companies like Huayou Cobalt and Liqin Resources are positioned to benefit from reduced export risks, while recycling firms like Greenmei are expected to see a 120% increase in cobalt recovery by 2025 [5][6]. - The performance elasticity of companies is linked to their ability to increase non-DRC production, with a 10% increase in Indonesian capacity potentially raising profit margins by 3-5% [6]. Conclusion - The cobalt market is experiencing a short-term supply contraction due to administrative interventions, with a dual strategy recommended for investors: short-term trading opportunities in non-DRC production and long-term investments in cobalt recycling and low-cobalt battery technologies [7].
A股能源金属板块盘初拉升,博迁新材封板涨停,腾远钴业、华友钴业、寒锐钴业、赣锋锂业、盛新锂能等跟涨。
news flash· 2025-06-11 01:38
Group 1 - The A-share energy metal sector experienced an initial surge, with significant gains observed in various companies [1] - Boqian New Materials reached the daily limit up, indicating strong investor interest and confidence [1] - Other companies such as Tengyuan Cobalt, Huayou Cobalt, Hanrui Cobalt, Ganfeng Lithium, and Shengxin Lithium Energy also saw increases in their stock prices, reflecting a broader positive trend in the sector [1]
6月9日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-09 10:15
Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]
寒锐钴业: 2024年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-06-08 08:07
证券代码:300618 证券简称:寒锐钴业 公告编号:2025-027 南京寒锐钴业股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 公司 2024 年度利润分配方案已获公司 2025 年 5 月 8 日召开的 2024 年年度股 东大会审议通过,现将利润分配事宜公告如下: 一、 股东大会审议通过利润分配方案情况 公司于 2025 年 5 月 8 日召开 2024 年年度股东大会会议,审议通过了《2024 年度利润分配预案》,以截至目前的总股本 308,324,991 股为基数,向全体股东每 元(含税),本次利润分配不送红股,不以公积金转增股本,剩余未分配利润转 结以后年度分配。 本次权益分派对象为:截至 2025 年 6 月 13 日下午深圳证券交易所收市后, 在中国证券登记结算有限责任公司深圳分公司(以下简称"中国结算深圳分公司") 登记在册的本公司全体股东。 五、 权益分派方法 本公司此次委托中国结算深圳分公司代派的 A 股股东现金红利将于 2025 年 6 月 16 日通过股东托管证券公司(或其他托管机构)直接划入其资金账户。 六、 调整相 ...
寒锐钴业(300618) - 2024年度权益分派实施公告
2025-06-08 07:45
证券代码:300618 证券简称:寒锐钴业 公告编号:2025-027 南京寒锐钴业股份有限公司 2024 年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 公司 2024 年度利润分配方案已获公司 2025 年 5 月 8 日召开的 2024 年年度股 东大会审议通过,现将利润分配事宜公告如下: 一、 股东大会审议通过利润分配方案情况 1、公司《2024 年度利润分配预案》具体情况如下: 公司于 2025 年 5 月 8 日召开 2024 年年度股东大会会议,审议通过了《2024 年度利润分配预案》,以截至目前的总股本 308,324,991 股为基数,向全体股东每 10 股派发现金股利人民币 1.50 元(含税),合计派发现金股利人民币 46,248,748.65 元(含税),本次利润分配不送红股,不以公积金转增股本,剩余未分配利润转 结以后年度分配。 若在分配方案实施前公司总股本由于可转债转股、股份回购、股权激励行权、 再融资新增股份上市等原因而发生变化的,将按分配比例不变的原则相应调整。 2、公司分配方案披露至实施期间,公司股本总额 ...
寒锐钴业(300618) - 关于为全资子公司向银行申请授信提供担保的公告
2025-06-03 08:52
证券代码:300618 证券简称:寒锐钴业 公告编号:2025-026 带责任担保,担保额度为人民币 7,000 万元,担保期限为每笔债权合同债务履行期 届满之日起至该债权合同约定的债务履行期届满之日后三年止; 南京寒锐钴业股份有限公司 关于为全资子公司向银行申请授信提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 南京寒锐钴业股份有限公司(以下简称"公司")于 2025 年 4 月 17 日召开 第五届董事会第十一次会议,会议以 5 票同意,0 票反对,0 票弃权审议通过《关 于公司及子公司 2025 年度融资及担保额度的议案》,并经 2024 年年度股东大会 审 议 通 过 。 具 体 内 容 详 见 公 司 于 2025 年 4 月 18 日在巨潮资讯网 (http://www.cninfo.com.cn/)披露的《关于公司及子公司 2025 年度融资及担保额 度的公告》(公告编号:2025-010)。 一、担保情况概述 因公司业务发展需要,公司拟为全资子公司向银行申请授信提供担保,具体 情况如下: 1、安徽寒锐新材料有限公司(以下简称"安 ...
寒锐钴业(300618) - 关于为全资子公司向银行申请授信提供担保的公告
2025-05-26 09:06
证券代码:300618 证券简称:寒锐钴业 公告编号:2025-025 南京寒锐钴业股份有限公司 关于为全资子公司向银行申请授信提供担保的公告 一、担保情况概述 因公司业务发展需要,安徽寒锐新材料有限公司(以下简称"安徽寒锐")向 华夏银行股份有限公司南京城东支行(以下简称"华夏银行南京城东支行")申请 不超过人民币 1.5 亿元敞口授信,由公司为上述授信提供连带责任担保,担保额度 为人民币 1.5 亿元,担保期限为主合同债务人履行债务期限届满之日起三年。 赣州寒锐新能源科技有限公司(以下简称"赣州寒锐")向华夏银行南京城东 支行申请不超过人民币 1.5 亿元敞口授信,由公司为上述授信提供连带责任担保, 担保额度为人民币 1.5 亿元,担保期限为主合同债务人履行债务期限届满之日起 三年。 上述融资涉及的授信及担保额度均包含在已审议的《关于公司及子公司 2025 年度融资及担保额度的议案》额度范围内,无需另行审议。 上述担保系公司为全资子公司提供担保,不涉及对合并报表外单位提供担保 的情形。公司及全资子公司提供担保总额未超过最近一期经审计净资产 100%,公 司及全资子公司不存在对资产负债率超过 70%的单位担 ...
有色金属行业跟踪周报:关税政策反复叠加美债拍卖遇冷,美国财政恶化驱使黄金价格再度走牛
Soochow Securities· 2025-05-25 08:23
Investment Rating - The report maintains an "Overweight" rating for the non-ferrous metals sector [1]. Core Views - The non-ferrous metals sector experienced a weekly increase of 1.26%, ranking it in the middle among all primary industries. Precious metals saw a significant rise of 5.58%, while industrial metals increased by 1.86% [1][14]. - The report highlights that tariff policies and a cooling U.S. Treasury auction have negatively impacted macroeconomic sentiment, leading to a weakening in industrial metals [1][24]. - Gold prices have surged due to deteriorating U.S. fiscal conditions, with COMEX gold closing at $3,357.70 per ounce, a 4.75% increase week-on-week [4][49]. Summary by Sections Market Review - The Shanghai Composite Index fell by 0.57%, while the non-ferrous metals sector rose by 1.26%, outperforming the index by 1.83 percentage points [14]. - Among the sub-sectors, precious metals led with a 5.58% increase, followed by industrial metals at 1.86%, while small metals and new materials declined [1][14]. Industrial Metals - **Copper**: As of May 23, LME copper was priced at $9,614 per ton, up 1.76% week-on-week. Supply remains tight due to mining incidents, but domestic smelting capacity is unaffected [2][32]. - **Aluminum**: LME aluminum closed at $2,466 per ton, down 0.62%. The supply side is impacted by the shutdown of bauxite mines in Guinea, leading to a significant rise in alumina prices [3][36]. - **Zinc**: LME zinc price increased by 0.78% to $2,713 per ton, with inventories decreasing [39]. - **Tin**: LME tin price fell by 0.46% to $32,665 per ton, with mixed inventory trends [45]. Precious Metals - Gold prices have risen significantly due to concerns over U.S. fiscal health, with a notable increase in both COMEX and SHFE gold prices [4][49]. - The report notes that the U.S. credit rating downgrade and a lackluster Treasury auction have further weakened market sentiment, contributing to the rise in gold prices [51][49]. Rare Earths - The report indicates stable supply and moderate demand for rare earths, with prices showing a slight decline [4]. News Highlights - The report discusses the implications of U.S. tariff policies and their potential impact on the market, particularly in relation to gold and industrial metals [4][51].
钴锂金属周报:强预期回归弱现实,商品波动加剧-20250519
Investment Rating - The report maintains an "Overweight" rating for the lithium and cobalt industry [2][5]. Core Insights - The report highlights a return to weak realities from strong expectations in the cobalt and lithium markets, with prices rebounding before retreating [14][15]. - The easing of US-China trade relations is expected to buffer the downward trend in lithium prices, although the overall market remains cautious [14][15]. - Cobalt market dynamics are characterized by a tightening supply and a cautious outlook from industry players, with many adopting a wait-and-see approach [16]. Summary by Sections 1. Cycle Assessment - The lithium sector is experiencing a slight price decline, with the Wuxi 2507 contract down 1.57% to 62,600 CNY/ton, and the Guangxi 2507 contract down 1.94% to 61,800 CNY/ton [14]. - Lithium concentrate prices have decreased to 712 USD/ton, down 13 USD/ton from the previous period [14]. - Recommended stocks for overweight positions include Zhongmin Resources, Yahua Group, Cangge Mining, Ganfeng Lithium, Keda Manufacturing, and Tibet Mining [14]. 2. Company and Industry Dynamics Tracking - The report notes significant developments in the industry, including a major discovery at the Tamarack copper-nickel project in Minnesota [19]. - The International Cobalt Institute predicts a shift to a cobalt shortage by the early 2030s, driven by demand growth outpacing supply [19]. - Salt Lake Co. has signed a project cooperation letter indicating a potential investment of around 300 million USD in Highfield Resources [19]. 3. Key Data: New Energy Material Production, Imports, and Metal Prices - Domestic production of lithium carbonate and lithium hydroxide saw a month-on-month decline in April [20]. - Lithium carbonate production decreased by 7% month-on-month but increased by 40% year-on-year [22]. - Cobalt sulfate production increased by 11% month-on-month and 48% year-on-year [23]. - The average price of battery-grade lithium carbonate fell by 2.15% to a range of 66,100-64,600 CNY/ton [57]. 4. Listed Company Profit Forecasts - Ganfeng Lithium is projected to have a PE ratio of 86.06 for 2025, while Tianqi Lithium is rated cautiously with a PE of 58.30 for 2025 [94]. - Huayou Cobalt is rated for an overweight position with a PE of 11.79 for 2025 [94].